• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Therapy Areas
  • Neuroscience

The following trials provide information to treat various types of disease of the brain and the central and local nervous systems, both for ongoing and completed clinical trials.  For more information on this therapy area please click here.

There are a number of ways to help you find trial information.  By using these filters you can find (i) recruiting status, (ii) therapy area, (iii) product and/or (iv) phase of drug development.  You can use one or all filters to identify your specific needs.

When a trial completes the results are reported here no later than one year after completion – this is why you may sometimes find that a Report is unavailable when you are searching through ‘closed’ trials.

  • Expand All
  • Collapse All
  • Pages
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next
  • collapse Effectiviness of Quetiapine
  • collapse Brain activation effects of Quetiapine during cognitive tasks in schizophrenic patients.
  • collapse Quetiapine (Seroquel) versus Valproat in the treatment of patients with bipolar rapid cycling. A pilot study
  • collapse Quetiapine augmentation in severe obsessive-compulsive disorder.
  • collapse Seroquel sustained release ( SR) vs. immediate release (IR) PET study.
  • collapse Treves, Quetiapine vs. Thioridazine in pat with PD
  • collapse Open-label, rater-blind study of Quetiapine versus Olanzapine in behavioural disorders of patients with dementia of the Alzheimer type (DAT).
  • collapse Quetiiapine treatment for psychosis accompanying Parkinson's disease: a double-blind study versus placebo.
  • collapse Randomised Double Blind, Placebo Controlled Study of Quetiapine Addition in OCD Patients Incompletely Responding to SSRIs
  • collapse Rater-blind, prospective study comparing the effect of clozapine vs quetiapine for the treatment of psychosis ins parkinsonian patients.
  • Pages
  • Previous
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • Next
  • Expand All
  • Collapse All

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013